Rusan Pharma Canada

Rusan Pharma is a research-driven pharmaceutical company specializing in the fields of addiction management, pain management, and neuro-psychiatry. The company is a major global supplier of de-addiction treatments, including buprenorphine and methadone, and has pioneered the use of transdermal drug delivery systems. Rusan operates multiple GMP-compliant manufacturing facilities and an R&D center focused on complex generics and innovative delivery formats. With a presence in over 50 countries, including a dedicated arm in Canada, the company provides critical healthcare solutions to government bodies and private institutions worldwide. Their portfolio includes a range of APIs and finished formulations targeting opioid and alcohol dependence.